Wang Qi, Zhu Fu-Xiang, Shi Min
Department of Colorectal Surgery, Shaoxing People's Hospital, Shaoxing 312000, Zhejiang Province, China.
Department of Anorectal Surgery, People's Hospital of Wuhan University, Wuhan 430060, Hubei Province, China.
World J Gastrointest Oncol. 2024 Jul 15;16(7):3299-3307. doi: 10.4251/wjgo.v16.i7.3299.
Advanced rectal cancer with submesenteric lymph node metastasis is a common complication of advanced rectal cancer, which has an important impact on the treatment and prognosis of patients.
To investigate the clinical and pathological characteristics of inferior mesenteric artery (IMA) root lymph node metastases in patients with rectal cancer. The findings of this study provided us with fresh medical information that assisted us in determining the appropriate treatment for these patients.
Our study searched PubMed, Google Scholar, and other databases and searched the relevant studies and reports on the risk factors of IMA root lymph node metastasis of rectal cancer published in the self-built database until December 31, 2023. After data extraction, the Newcastle-Ottawa scale was used to evaluate the quality of the included literature, and RevMan5.3 software was used for meta-analysis and heterogeneity testing. The fixed effect modules without heterogeneity were selected to combine the effect size, and the random effect modules with heterogeneity were selected to combine the effect size. The cause of heterogeneity was found through sensitivity analysis, and the data of various risk factors were combined to obtain the final effect size, odds ratio (OR) value, and 95% confidence interval (CI). Publication bias was tested by drawing funnel plots.
A total of seven literature were included in this study. By combining the OR value of logistic multivariate regression and the 95%CI of various risk factors, we concluded that the risk factors for lymph node metastasis in the IMA region of rectal cancer were as follows: Preoperative carcinoembryonic antigen (CEA) > 5 ng/mL (OR = 0.32, 95%CI: 0.18-0.55, < 0.05), tumor located above peritoneal reflexive (OR = 3.10, 95%CI: 1.78-5.42, < 0.05), tumor size ≥ 5 cm (OR = 0.36, 95%CI: 0.22-0.57, < 0.05), pathological type (mucinous adenocarcinoma/sig-ring cell carcinoma) (OR = 0.23, 95%CI: 0.13-0.41, < 0.05), degree of tumor differentiation (low differentiation) (OR = 0.17, 95%CI: 0.10-0.31, < 0.05), tumor stage (T3-4 stage) (OR = 0.11, 95%CI: 0.04-0.26, < 0.05), gender and age were not risk factors for IMA root lymph node metastasis in rectal cancer ( > 0.05).
Preoperative CEA level, tumor location, tumor size, tumor pathologic type, tumor differentiation, and T stage were correlated with IMA root lymph node metastasis.
伴有肠系膜下淋巴结转移的晚期直肠癌是晚期直肠癌的常见并发症,对患者的治疗及预后有重要影响。
探讨直肠癌患者肠系膜下动脉(IMA)根部淋巴结转移的临床及病理特征。本研究结果为我们提供了新的医学信息,有助于我们确定这些患者的合适治疗方案。
本研究检索了PubMed、谷歌学术等数据库,并检索自建数据库中截至2023年12月31日发表的关于直肠癌IMA根部淋巴结转移危险因素的相关研究及报告。数据提取后,采用纽卡斯尔-渥太华量表评估纳入文献的质量,并使用RevMan5.3软件进行Meta分析和异质性检验。选择无异质性的固定效应模型合并效应量,选择有异质性的随机效应模型合并效应量。通过敏感性分析找出异质性原因,合并各危险因素的数据以获得最终效应量、比值比(OR)值和95%置信区间(CI)。通过绘制漏斗图检验发表偏倚。
本研究共纳入7篇文献。通过合并逻辑多元回归的OR值及各危险因素的95%CI,我们得出直肠癌IMA区域淋巴结转移的危险因素如下:术前癌胚抗原(CEA)>5 ng/mL(OR = 0.32,95%CI:0.18 - 0.55,<0.05),肿瘤位于腹膜反折以上(OR = 3.10,95%CI:1.78 - 5.42,<0.05),肿瘤大小≥5 cm(OR = 0.36,95%CI:0.22 - 0.57,<0.05),病理类型(黏液腺癌/印戒细胞癌)(OR = 0.23,95%CI:0.13 - 0.41,<0.05),肿瘤分化程度(低分化)(OR = 0.17,95%CI:0.10 - 0.31,<0.05),肿瘤分期(T3 - 4期)(OR = 0.11,95%CI:0.04 - 0.26,<0.05),性别和年龄不是直肠癌IMA根部淋巴结转移的危险因素(>0.05)。
术前CEA水平、肿瘤位置、肿瘤大小、肿瘤病理类型、肿瘤分化程度及T分期与IMA根部淋巴结转移相关。